Current methods for capsular typing of Streptococcus pneumoniae

Elita Jauneikaite1, Anna S Tocheva2, Johanna M C Jefferies3

  • 1Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, UK; Infectious Diseases, Genome Institute of Singapore, 138672, Singapore.

Insights

Tracking Streptococcus pneumoniae serotypes is crucial due to vaccine limitations. This study reviews methods for pneumococcal capsule typing to guide surveillance and future vaccine development.

Area of Science:

  • Microbiology
  • Vaccinology
  • Genomics

Background:

  • Streptococcus pneumoniae causes significant respiratory illness, particularly in young children and the elderly.
  • Current pneumococcal conjugate vaccines (PCV) cover a limited number of the 98 known serotypes, necessitating surveillance for non-vaccine serotypes.
  • Post-PCV implementation requires rapid, accurate, and cost-effective methods for pneumococcal serotyping.

Purpose of the Study:

  • To review and describe serotyping methods for Streptococcus pneumoniae published before November 10, 2014.
  • To evaluate available methods for pneumococcal capsule typing in the context of post-vaccine surveillance.
  • To inform the selection of appropriate typing methods for monitoring vaccine impact and future vaccine design.

Main Methods:

  • A systematic review of published pneumococcal capsule typing methods.
  • Categorization of identified methods into serological, semi-automated molecular, and whole-genome sequencing approaches.
  • Analysis of 16 distinct typing methods, including the gold-standard Quellung reaction.

Main Results:

  • Six serological, eight semi-automated molecular, and one whole-genome sequencing method were identified.
  • No single method is universally optimal for all pneumococcal typing applications.
  • The Quellung reaction remains the gold-standard, but resource and sample considerations are vital for method selection.

Conclusions:

  • Selecting the most appropriate pneumococcal typing method depends on laboratory resources, sample type, and desired turnaround time.
  • A combination of phenotypic and genotypic methods is likely optimal for monitoring PCV impact and informing future vaccine formulations.
  • Continued surveillance and development of effective typing strategies are essential for controlling pneumococcal disease.

Related Concept Videos

Special Staining Techniques01:13

Special Staining Techniques

Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...
1.7K
Methods of Classification and Identification01:28

Methods of Classification and Identification

Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...
2.1K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67